Each capsule contains:TzymeTM Probiotic Blend 442mg of:
---Lactobacillus plantarum 3 billion CFU
---Lactobacillus sporogenes 380 million CFU
---Lactobacillus salivarius 300 million CFU
---Bifidobacterium longum 200 million CFU
---Lactobacillus casei 225 million CFU
---Lactobacillus acidophilus 1 billion CFU
Jerusalem Artichoke tuber 20mg
Lactoferrin 10mgOther Ingredients:
Vegetarian Capsules (cellulose and water).Contains NO:
Enzyme activity is measured in Food Chemical Codex (FCC) units.
Adults: Take one (1) capsule upon arising and/or at bedtime. Drink at least 8 oz. of water with each dosage. If you have difficulty swallowing capsules, then remove contents from capsule, mix with a small amount of tepid water, and ingest immediately. Dosage may be increased according to need as directed by your health care professional. Refrigerate for optimum activity.
Tzyme+óGÇP-ó is a trademark of a proprietary blend of highly active, functional microorganisms. These microorganisms are pH balanced and GI tract stable. This blend is formulated to enhance the digestive process and impact systemic benefits.*
1. Salminen, S. & Salminen, E. +óGé¼+ôLactulose, lactic acid bacteria, intestinal microecology and mucosal protection+óGé¼-¥ Scand J Gastroenterol Suppl 1997; 222: 45-8.
2. Olasupo, W.A. +óGé¼+ôBacteriocins of Lactobacillus plantarum strains from fermented foods+óGé¼-¥ Folia Microbiol 1996; 41: 130-136.
3. Adawi, D., et al. +óGé¼+ôEffect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat+óGé¼-¥ Hepatology 1997; 25: 642-7.
4. Schiffrin, E.J. et al. +óGé¼+ôImmune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection+óGé¼-¥ Am J Clin Nutr 1997; 66: 515S-20S.
5. Rangavajhyala, N. et al. +óGé¼+ôNonlipopolysaccharide component(s) of Lactobacillus acidophilus stimulate(s) the production of interleukin-1 alpha and tumor necrosis factor-alpha by murine macrophages+óGé¼-¥ Nutr Cancer 1997; 28: 130-4.
6. Sekine, K. et al. +óGé¼+ôInhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferin concomitantly with azoxymethane+óGé¼-¥ Cancer Lett 1997; 121: 211-6.
7. Takahashi, T. et al. +óGé¼+ôEffects of orally ingested Bifidobacterium longum on the mucosal IgA response of mice to dietary antigens+óGé¼-¥ Biosci Biotechnol Biochem 1998; 62: 10-15.
8. McClellan, K.A. +óGé¼+ôMucosal defense of the outer eye+óGé¼-¥ Surv Ophthalmol 1997; 42: 233-46.
9. Teraguchi, S. et al. +óGé¼+ôOrally administered bovine lactoferrin inhibits bacterial translocation in mice fed bovine milk+óGé¼-¥ Appl Environ Microbiol 1995; 61: 4131-4.
10. Roberfroid, M.B. +óGé¼+ôHealth benefits of non-digestible oligosaccharides+óGé¼-¥ Adv Exp Med Biol 1997; 427: 211-9.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.